Department of Urology, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.
Urology Department, Città della Salute e della Scienza, Torino, Italy.
J Sex Med. 2022 Feb;19(2):377-384. doi: 10.1016/j.jsxm.2021.12.006. Epub 2021 Dec 31.
Several treatment options for urethral complications following metoidioplasty in transmen are described in the literature, yet little is known with regard to the surgical outcomes.
The aim of this study was to analyze the surgical outcomes after treatment of urethral strictures and urethral fistulas following metoidioplasty.
A multicenter retrospective cohort study was conducted with transmen treated for strictures and fistulas after metoidioplasty in 3 tertiary referral centers.
The primary outcome was the recurrence-free rate after surgical treatment of urethral strictures and urethral fistulas over a time period of 3 years postoperatively.
Of 96 transmen included in this study with a urethral complication, 44 (46%) experienced a urethral fistula, 31 (32%) a urethral stricture, and 21 (22%) both complications simultaneously. The recurrence-free rate for urethral strictures following endoscopic management (ie, urethral dilation or direct visual internal urethrotomy) was 61% after 1, 50% after 2, and 43% after 3 years, compared to 82% following open treatment options after 1, 2, and 3 years (P = .002). Open treatment options were Heineke-Mikulicz procedure (7/9, 78% success), excision and primary anastomosis (3/3, 100%), 2-stage without graft (9/9, 100%), pedicled flap urethroplasty (1/1, 100%), and buccal mucosa graft urethroplasty (2/4 [50%] single-stage, 1/1 [100%] 2-stage). The recurrence-free rate for small urethral fistulas located at the pendulous urethra was 79% after 1, and 72% after 2 and 3 years, compared to 45% after 1, and 41% after 2 and 3 years for large fistulas, generally located at the urethral anastomoses of the fixed urethra. Treatment options for urethral fistulas were fistulectomy (26/48, 54%), fistulectomy & (redo) colpectomy (7/11, 64%), buccal mucosa graft urethroplasty (1/1, 100%), and retubularization of the urethral plate (3/4, 75%). A colpectomy before or during reoperation of a urethral fistula at the proximal urethral anastomosis showed higher success rates compared to without a colpectomy (7/11 [64%] vs 2/13 [15%] respectively, P = .03).
This study provides insight in the treatment possibilities and corresponding outcomes of urethral complications following metoidioplasty in transmen.
STRENGTHS & LIMITATIONS: Strengths were the relatively large sample size and the overview of multiple treatment options available. Limitations were the heterogeneity of the cohort, underexposure of some surgical modalities, and absence of patient-reported outcomes.
Open surgical techniques show better long-term outcomes in the management of urethral strictures compared to endoscopic options, and a colpectomy is beneficial before or during urethral fistula repair at the proximal urethral anastomosis. de Rooij FPW, Falcone M, Waterschoot M, et al. Surgical Outcomes After Treatment of Urethral Complications Following Metoidioplasty in Transgender Men. J Sex Med 2022;19:377-384.
文献中描述了几种治疗跨性别男性行阴蒂成形术后尿道并发症的方法,但对于手术结果知之甚少。
本研究旨在分析治疗阴蒂成形术后尿道狭窄和尿道瘘的手术结果。
对 3 家三级转诊中心治疗的 96 例发生尿道狭窄和瘘管的跨性别男性进行了多中心回顾性队列研究。
主要结局是术后 3 年尿道狭窄和瘘管手术治疗的无复发率。
在这项研究中,96 例发生尿道并发症的跨性别男性中,44 例(46%)发生尿道瘘,31 例(32%)发生尿道狭窄,21 例(22%)同时发生两种并发症。内镜治疗(即尿道扩张或直接可视尿道内切开术)后尿道狭窄的无复发率为 1 年后 61%,2 年后 50%,3 年后 43%,而 1 年后开放治疗的无复发率为 82%,2 年后为 70%,3 年后为 64%(P=0.002)。开放治疗方案包括 Heineke-Mikulicz 手术(9/9,78%成功)、切除和一期吻合术(3/3,100%)、无移植物的两期手术(9/9,100%)、带蒂皮瓣尿道成形术(1/1,100%)和颊黏膜移植物尿道成形术(4/4[50%]一期,1/1[100%]二期)。位于悬垂尿道的小尿道瘘的无复发率为 1 年后 79%,2 年后和 3 年后为 72%,而位于固定尿道尿道吻合处的大瘘的无复发率为 1 年后 45%,2 年后和 3 年后为 41%。尿道瘘的治疗方案包括瘘管切除术(26/48,54%)、瘘管切除术和(再次)阴道切除术(7/11,64%)、颊黏膜移植物尿道成形术(1/1,100%)和尿道板再管化(3/4,75%)。在近端尿道吻合处尿道瘘的再手术前或手术中进行阴道切除术显示出比不进行阴道切除术更高的成功率(分别为 7/11[64%]与 2/13[15%],P=0.03)。
本研究提供了阴蒂成形术后尿道并发症治疗可能性和相应结果的见解。
本研究的优势在于样本量较大,并且可以提供多种治疗选择。局限性在于队列的异质性、某些手术方法的曝光不足以及缺乏患者报告的结果。
与内镜治疗相比,开放手术技术在治疗尿道狭窄方面具有更好的长期结果,在近端尿道吻合处尿道瘘修复前或修复时进行阴道切除术有益。